Bugworks Research Anand Anandkumar wins for his scientific innovation

Bugworks Research has developed a way to mitigate a key component of drug-resistance and enable antibiotics to enter superbugs,bacteria that have become resistant to antibiotic drugsAugust 18, 2017, 20:44 IST

Representative image Anand Anandkumar, CEO of Bugworks Research, was thankful that The Economic Times has given a platform for scientific innovation.

"At a time where the business narrative is predominantly dominated by tech, it is so heartening to see the Economics Times giving a platform for Science," said Anandkumar, who collected The Top Innovator on behalf of his team.

Bugworks Research has developed a way to mitigate a key component of drug-resistance and enable antibiotics to enter superbugs,bacteria that have become resistant to antibiotic drugs.

The novel class of Antibiotics that Bugworks is working on, has the potential of curing a wide range of Hospital and community acquired infections caused by deadly Superbugs. "Sadly, India is at the epicentre of this," said Anandkumar.

Anandkumar was also thankful to his team and family for being pillars of support.